Impressive results came out on drugs from Amgen, Arrowhead Pharmaceuticals, and Crispr Therapeutics. Their shares are all lower this week.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
Heart-Drug Breakthroughs Can’t Stop Biotech Stocks From Sliding ·
Barrons.com
·
Dreamstime
